CytomX Therapeutics Inc
CTMX
Market Cap$393.86M
Close$
$6.51
160.6% upside
Current Fair Value
160.6% upsideUndervalued by 160.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $393.86 Million |
|---|---|
| Enterprise Value | $387.91 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.38 |
| Beta | 2.12 |
| Outstanding Shares | 87,121,502 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 5.24 |
|---|---|
| PEG | 7.42 |
| Price to Sales | 2.5 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.63 |
| Enterprise Value to EBIT | 10.79 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 1.66 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About CytomX Therapeutics Inc
CEO: Sean McCarthy